MET and non-small cell lung carcinoma: Recently, Overbeck et al. have added a top-level category of MET-GCNG/GA in NSCLC, corresponding to an average MET-GCN/cell ≥10, which was observed in a subset of poorly differentiated adenocarcinomas with unfavorable prognosis [25].